These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15472900)

  • 1. Apoptosis of circulating tumor cells in prostate cancer patients.
    Larson CJ; Moreno JG; Pienta KJ; Gross S; Repollet M; O'hara SM; Russell T; Terstappen LW
    Cytometry A; 2004 Nov; 62(1):46-53. PubMed ID: 15472900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells predict survival in patients with metastatic prostate cancer.
    Moreno JG; Miller MC; Gross S; Allard WJ; Gomella LG; Terstappen LW
    Urology; 2005 Apr; 65(4):713-8. PubMed ID: 15833514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of circulating tumor cells by fluorescence in situ hybridization.
    Swennenhuis JF; Tibbe AG; Levink R; Sipkema RC; Terstappen LW
    Cytometry A; 2009 Jun; 75(6):520-7. PubMed ID: 19291800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer.
    Shaffer DR; Leversha MA; Danila DC; Lin O; Gonzalez-Espinoza R; Gu B; Anand A; Smith K; Maslak P; Doyle GV; Terstappen LW; Lilja H; Heller G; Fleisher M; Scher HI
    Clin Cancer Res; 2007 Apr; 13(7):2023-9. PubMed ID: 17404082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomagnetic quantification of circulating tumoral cells in patients with prostate cancer: clinical and pathological correlation.
    Resel Folkersma L; Olivier Gómez C; San José Manso L; Veganzones de Castro S; Galante Romo I; Vidaurreta Lázaro M; de la Orden GV; Arroyo Fernández M; Díaz Rubio E; Silmi Moyano A; Maestro de Las Casas MA
    Arch Esp Urol; 2010; 63(1):23-31. PubMed ID: 20157216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
    Cai QQ; Huang HQ; Lin TX; Jiang WQ
    Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
    Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
    Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
    Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model.
    Helzer KT; Barnes HE; Day L; Harvey J; Billings PR; Forsyth A
    Cancer Res; 2009 Oct; 69(19):7860-6. PubMed ID: 19789350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
    Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
    Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of circulating tumor cells (CTCs) in prostate cancer patients with low-volume tumors.
    Ali A; Furusato B; Ts'o PO; Lum ZP; Elsamanoudi S; Mohamed A; Srivastava S; Moul JW; Brassell SA; Sesterhenn IA; McLeod DG
    Pathol Int; 2010 Oct; 60(10):667-72. PubMed ID: 20846264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry.
    Allan AL; Vantyghem SA; Tuck AB; Chambers AF; Chin-Yee IH; Keeney M
    Cytometry A; 2005 May; 65(1):4-14. PubMed ID: 15810015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
    Paris PL; Kobayashi Y; Zhao Q; Zeng W; Sridharan S; Fan T; Adler HL; Yera ER; Zarrabi MH; Zucker S; Simko J; Chen WT; Rosenberg J
    Cancer Lett; 2009 May; 277(2):164-73. PubMed ID: 19162393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer.
    Danila DC; Heller G; Gignac GA; Gonzalez-Espinoza R; Anand A; Tanaka E; Lilja H; Schwartz L; Larson S; Fleisher M; Scher HI
    Clin Cancer Res; 2007 Dec; 13(23):7053-8. PubMed ID: 18056182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
    Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
    Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients.
    Balic M; Dandachi N; Hofmann G; Samonigg H; Loibner H; Obwaller A; van der Kooi A; Tibbe AG; Doyle GV; Terstappen LW; Bauernhofer T
    Cytometry B Clin Cytom; 2005 Nov; 68(1):25-30. PubMed ID: 16142788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients.
    Okumura Y; Tanaka F; Yoneda K; Hashimoto M; Takuwa T; Kondo N; Hasegawa S
    Ann Thorac Surg; 2009 Jun; 87(6):1669-75. PubMed ID: 19463575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global gene expression profiling of circulating tumor cells.
    Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
    Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.